Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas

Malignant gliomas have a poor prognosis despite advances in diagnosis and therapy. Although postoperative temozolomide and radiotherapy improve overall survival in glioblastoma patients, most patients experience a recurrence. The prognosis of recurrent malignant gliomas is dismal, and more effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Katsuyuki, Siedow, Michael R., Chakravarti, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139866/
https://www.ncbi.nlm.nih.gov/pubmed/21804824
http://dx.doi.org/10.1155/2012/193436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139866/
https://www.ncbi.nlm.nih.gov/pubmed/21804824
http://dx.doi.org/10.1155/2012/193436

Ejemplares similares